13:49 : Vertex Pharmaceuticals (VRTX) comes off a trading halt after tripping ... -
Vertex Pharmaceuticals (VRTX) comes off a trading halt after tripping circuit breaks still showing a solid 7.4% gain on momentum built from the firm's FDA approval for Kalydeco. Sanford Bernstein analyst Geoffrey Porges sees ...
12:27 : Vertex Pharmaceuticals ([[VRTX]] +1.4%) says the FDA has accepted a New ... -
Vertex Pharmaceuticals (VRTX +1.4%) says the FDA has accepted a New Drug Application for its cystic-fibrosis drug Kalydecotm, and granted the company's request for six-month priority review. The drug targets the defective ...